Epidermal Growth Factor Receptor (EGFR) mutations are critical biomarkers in the field of oncology, especially concerning lung cancer. These mutations can significantly influence both the prognosis and the choice of treatment for patients. The EGFR Mutation Analysis Test, particularly focusing on exons 18, 19, 20, and 21, is designed to detect such mutations, thereby enabling […]











